Mayo Clinic News Network

News Resources


Items tagged as "Edith Perez"

Dados de estudos clínicos mundiais de dois medicamentos para câncer de mama HER2-positivo mostra que o trastuzumabe deve permanecer como o padrão de tratamento

JACKSONVILLE, Flórida 30 de setembro de 2014 — Análises em mais de 8 mil mulheres, que participaram do maior estudo mundial de dois medicamentos para o câncer de mama HER2-positivo, reforçam outras descobertas de estudos clínicos mostrando que o trastuzumabe (Herceptin) deve permanecer como o padrão de tratamento desse tipo [...]

Created by Paul Scotti

Datos de un ensayo clínico realizado a nivel mundial con dos fármacos contra el cáncer de mama HER2-positivo muestran que el trastuzumab debería permanecer como tratamiento estándar

JACKSONVILLE, Florida, 30 de septiembre 2014 — Investigaciones en más de 8.000 mujeres, que participaron en el estudio más grande del mundo de dos tratamientos para el cáncer de mama HER2-positivo, refuerzan otros hallazgos de este ensayo clínico que demuestran que el fármaco trastuzumab (Herceptin) debiera seguir siendo el tratamiento [...]

Created by Paul Scotti

Data From Worldwide Trial of Two HER2-Positive Breast Cancer Drugs Shows That Trastuzumab Should Remain as Standard of Care

JACKSONVILLE, Fla., Sept. 29, 2014 — Analysis of more than 8,000 women who participated in the world’s largest study of two treatments for HER2-positive breast cancer reinforces other findings from the clinical trial showing that trastuzumab (Herceptin) should remain the standard of care for this cancer, says a Mayo Clinic [...]

Created by Paul Scotti

Medical Experts for Media - Cancer

Jan Buckner, M.D. Edward Creagan, M.D. Matthew Goetz, M.D. Stephanie Hines, M.D. Amber Isley, M.D. Judith Kaur, M.D. Charles Loprinzi, M.D. Sarah A. McLaughlin, M.D. Ruben Mesa, M.D. Timothy Moynihan, M.D. Edith Perez, M.D. Sandhya Pruthi, M.D. S. Vincent Rajkumar, M.D. Deborah Rhodes, M.D. Tait Shanafelt, M.D. Keith Stewart, M.D. [...]

Created by Shawn Bishop

Mayo Clinic IDs Genes That Predict Whether Trastuzumab Will Work for Breast Cancer Patients

SAN ANTONIO, Texas — Adding the drug trastuzumab to chemotherapy prevents cancer recurrence and improves survival in a large number of women with early stage HER2-positive breast cancer. But trastuzumab does not stop tumors from returning in about 25 percent of patients — and oncologists haven't been able to identify [...]

Created by mayonewsreleases

Two Drugs Help Fight Kidney, Breast Cancer

JACKSONVILLE, Fla. — July 31, 2012.  A potentially powerful new approach to treating two lethal metastatic cancers — triple negative breast cancer and clear cell renal cell carcinoma, the most common form of kidney cancer — has been discovered by researchers at Mayo Clinic in Florida. In the online issue [...]

Created by Paul Scotti

Mayo Clinic Breast Cancer Study Finds New Type of Mutation

JACKSONVILLE, Fla. — April 10, 2012.   Mayo Clinic researchers have discovered a new class of molecular mutation in various forms of breast cancer, a finding that may shed new light on development and growth of different types of breast tumors. Called fusion transcripts, the mutated forms of RNA may also [...]

Created by Paul Scotti

Load More